ACTIVE NOT RECRUITING
NCT07581379
Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations
This observational study evaluates the effectiveness of computed tomography (CT) imaging surveillance after curative-intent treatment for stage I-IIIA non-small cell lung cancer (NSCLC) in a diverse U.S. population.
The main questions are:
How do CT surveillance use and adherence vary by race, ethnicity, and socioeconomic status?
Does semi-annual CT surveillance improve outcomes compared with annual surveillance?
Adults ages 20-90 with stage I-IIIA NSCLC treated between 2012 and 2026 will be identified using OneFlorida+ electronic health records, tumor registry data, claims, and clinical notes. Patients will be followed for up to five years after curative-intent therapy to evaluate surveillance patterns, recurrence, second primary lung cancers, complications, and survival.
Lung Neoplasms
Second Primary Lung Cancer (SPLC)
Non-Small Cell Lung Cancer (NSCLC), Stage I-IIIA
+1